Immunohistochemical labeling of the mu opioid receptor carboxy terminal splice variant mMOR-1B4 in the mouse central nervous system

Brain Research

Volumn 1099, Issue 1, 2006, Pages 33-43

  Zhang, Yahong ^a   Pan, Yin Xian ^a   Kolesnikov, Yuri ^a   Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Clone; MOR 1; Morphine; Opiate; Opioid receptor; Splice variant

Indexed keywords

MU OPIATE RECEPTOR; MU OPIATE RECEPTOR 1B4; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ANTERIOR HORN CELL; AREA POSTREMA; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN NUCLEUS; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; HABENULA; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; LOCUS CERULEUS; MOTONEURON; MOUSE; NERVE PROJECTION; NONHUMAN; OCULOMOTOR NUCLEUS; OLFACTORY BULB; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN VARIANT; PURKINJE CELL; RAPHE NUCLEUS; RED NUCLEUS; RETICULAR FORMATION; RNA SPLICING; SENSORY NERVE; SPINAL CORD; SPINAL CORD DORSAL HORN; SPINAL GANGLION; STRIA TERMINALIS; SUBSTANTIA NIGRA; THALAMUS; TRIGEMINAL NUCLEUS; VENTRAL TEGMENTUM;

ALTERNATIVE SPLICING; ANIMALS; CENTRAL NERVOUS SYSTEM; IMMUNOHISTOCHEMISTRY; MALE; MICE; PEPTIDE FRAGMENTS; RECEPTORS, OPIOID, MU; TISSUE DISTRIBUTION; VARIATION (GENETICS);

EID: 33746093526     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.04.133     Document Type: Article

References (73)

1. Abbadie C., and Pasternak G.W. Differential in vivo internalization of MOR-1 and MOR-1C by morphine. NeuroReport 12 (2001) 3069-3072
2. Abbadie C., Pan Y.-X., and Pasternak G.W. Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C and MOR-1-like immunoreactivity: evidence for region-specific processing. J. Comp. Neurol. 419 (2000) 244-256
3. Abbadie C., Gultekin S.H., and Pasternak G.W. Immunohistochemical localization of the carboxy terminus of the novel mu opioid receptor splice variant MOR-1C within the human spinal cord. NeuroReport 11 (2000) 1953-1957
4. Abbadie C., Pasternak G.W., and Aicher S.A. Presynaptic localization of the carboxy-terminus epitopes of the mu opioid receptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord. Neuroscience 106 (2001) 833-842
5. Abbadie C., Pan Y.-X., and Pasternak G.W. Immunohistochemical study of the expression of exon11-containing mu opioid receptor variants in the mouse brain. Neuroscience i (2004) 419-430
6. Anton B., Husain M., Kaufman D., Stickney E., Keith Jr. D., Evans C.J., and Miotto K. Localization of mu, delta and kappa opioid receptor mRNAs in human brain. Regul. Pept. 54 (1994) 11-12
7. Arvidsson U., Riedl M., Chakrabarti S., Lee J.-H., Nakano A.H., Dado R.J., Loh H.H., Law P.-Y., Wessendorf M.W., and Elde R. Distribution and targeting of a m-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15 (1995) 3328-3341
8. Atweh S.F., and Kuhar M.J. Autoradiographic localization of opiate receptors in rat brain: III. The telencephalon. Brain Res. 134 (1977) 393-405
9. Atweh S.F., and Kuhar M.J. Autoradiographic localization of opiate receptors in rat brain: II. The brain stem. Brain Res. 129 (1977) 1-12
10. Atweh S.F., and Kuhar M.J. Autoradiographic localization of opiate receptors in rat brain: I. Spinal cord and lower medulla. Brain Res. 124 (1977) 53-67
11. Bare L.A., Mansson E., and Yang D. Expression of two variants of the human m opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett. 354 (1994) 213-216
12. Billinton A., Ige A.O., Bolam J.P., White J.H., Marshall F.H., and Emson P.C. Advances in the molecular understanding of GABA(B) receptors. Trends Neurosci. 24 (2001) 277-282
13. Blondel O., Gastineau M., Dahmoune Y., Langlois M., and Fischmeister R. Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus. J. Neurochem. 70 (1998) 2252-2261
14. Bolan E.A., Pasternak G.W., and Pan Y.-X. Functional analysis of MOR-1 splice variants of the mu opioid receptor gene, Oprm. Synapse 51 (2004) 11-18
15. Chang A., Emmel D.W., Rossi G.C., and Pasternak G.W. Methadone analgesia in morphine-insensitive CXBK mice. Eur. J. Pharmacol. 351 (1998) 189-191
16. Chen Y., Mestek A., Liu J., Hurley J.A., and Yu L. Molecular cloning and functional expression of a m-opioid receptor from rat brain. Mol. Pharmacol. 44 (1993) 8-12
17. Elmhurst J.L., Xie Z., O'Dowd B.F., and George S.R. The splice variant D3nf reduces ligand binding to the D3 dopamine receptor: evidence for heterooligomerization. Brain Res. Mol. Brain Res. 80 (2000) 63-74
18. Eppler C.M., Hulmes J.D., Wang J.-B., Johnson B., Corbett M., Luthin D.R., Uhl G.R., and Linden J. Purification and partial amino acid sequence of a m opioid receptor from rat brain. J. Biol. Chem. 268 (1993) 26447-26451
19. Evans C.J., Hammond D.L., and Frederickson R.C.A. The opioid peptides. In: Pasternak G.W. (Ed). The Opiate Receptors (1988), Humana Press, Clifton, NJ 23-74
20. George S.R., Fan T., Xie Z., Tse R., Tam V., Varghese G., and O'Dowd B.F. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J. Biol. Chem. 275 (2000) 26128-26135
21. Gerald C., Adham N., Kao H.-T., Olsen M.A., Laz T.M., Schechter L.E., Bard J.A., Vaysse P.J.J., Hartig P.R., Branchek T.A., and Weinshank R.L. The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO J. 14 (1995) 2806-2815
22. Gomes I., Jordan B.A., Gupta A., Trapaidze N., Nagy V., and Devi L.A. Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J. Neurosci. 20 (2000) RC110
23. Guiramand J., Montmayeur J.P., Ceraline J., Bhatia M., and Borrelli E. Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins. J. Biol. Chem. 270 (1995) 7354-7358
24. Heidmann D.E., Szot P., Kohen R., and Hamblin M.W. Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing. Neuropharmacology 37 (1998) 1621-1632
25. Hsu S.M., Raine L., and Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Clin. Pathol. 75 (1981) 734-738
26. Jordan B.A., and Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399 (1999) 697-700
27. Kuhar M.J., Pert C.B., and Snyder S.H. Regional distribution of opiate receptor binding in monkey and human brain. Nature 245 (1973) 447-450
28. Malherbe P., Kew J., Richards J., Knoflach F., Kratzeisen C., Zenner M., Faull R., Kemp J., and Mutel V. Identification and characterization of a novel splice variant of the metabotropic glutamate receptor 5 gene in human hippocampus and cerebellum. Mol. Brain Res. 109 (2002) 168-178
29. Mansour A., Fox C.A., Burke S., and Watson S.J. Immunohistochemical localization of the mu opioid receptors. Regul. Pept. 54 (1994) 179-180
30. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., and Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 350 (1994) 412-438
31. Mansour A., Fox C.A., Burke S., Akil H., and Watson S.J. Immunohistochemical localization of the cloned m opioid receptor in the rat CNS. J. Chem. Neuroanat. 8 (1995) 283-305
32. Martin N.A., and Prather P.L. Interaction of co-expressed m- and d-opioid receptors in transfected rat pituitary GH3 cells. Mol. Pharmacol. 59 (2001) 774-783
33. Moulin D.E., Ling G.S.F., and Pasternak G.W. Unidirectional analgesic cross tolerance between morphine and levorphanol in the rat. Pain 33 (1988) 233-239
34. Nakamura M., Sakanaka C., Aoki Y., Ogasawara H., Tsuji T., Kodama H., Matsumoto T., Shimizu T., and Noma M. Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing-Isolation, genomic structure, and functional expression of the receptors. J. Biol. Chem. 270 (1995) 30102-30110
35. Namba T., Sugimoto Y., Negishi M., Irie A., Ushikubi F., Kakizuka A., Ito S., Ichikawa A., and Narumiya S. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365 (1993) 166-170
36. Pan Y.X. Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Oprm) that generates eight splice variants. Gene 295 (2002) 97-108
37. Pan Y.X., Xu J., Bolan E.A., Abbadie C., Chang A., Zuckerman A., Rossi G.C., and Pasternak G.W. Identification and characterization of three new alternatively spliced mu opioid receptor isoforms. Mol. Pharmacol. 56 (1999) 396-403
38. Pan Y.X., Xu J., Bolan E., Chang A., Mahurter L., Rossi G., and Pasternak G.W. Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F. FEBS Lett. 466 (2000) 337-340
39. Pan Y.-X., Xu J., Mahurter L., Bolan E.A., Xu M.M., and Pasternak G.W. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 14084-14089
40. Pan Y.-X., Bolan E., and Pasternak G.W. Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype. Biochem. Biophys. Res. Commun. 297 (2002) 659-663
41. Pan Y.X., Xu J., Mahurter L., Xu M.M., Gilbert A.-K., and Pasternak G.W. Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1X. Biochem. Biophys. Res. Commun. 301 (2003) 1057-1061
42. Pan L., Xu J., Yu R., Xu M., Pan Y.X., and Pasternak G.W. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene Oprm. Neuroscience 133 (2005) 209-220
43. Pan Y.X., Xu J., Bolan E., Moskowitz H.S., Xu M., and Pasternak G.W. Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol. Pharmacol. 68 (2005) 866-875
44. Pan Y.X., Xu J., Bolan E., Moskowitz H.S., Xu M., and Pasternak G.W. Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol. Pharmacol. 68 (2005) 866-875
45. Pan Y.X., Xu J., Bolan E., Moskowitz H.S., Xu M., and Pasternak G.W. Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol. Pharmacol. 68 (2005) 866-875
46. Pan Y.X., Xu J., Bolan E., Moskowitz H.S., Xu M., and Pasternak G.W. Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol. Pharmacol. 68 (2005) 866-875
47. Pan Y.X., Xu J., Bolan E., Moskowitz H.S., Xu M., and Pasternak G.W. Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol. Pharmacol. 68 (2005) 866-875
48. Pasternak G.W., and Snyder S.H. Identification of a novel high affinity opiate receptor binding in rat brain. Nature 253 (1975) 563-565
49. Pasternak G.W. Incomplete cross tolerance and multiple mu opioid peptide receptors. Trends Pharmacol. Sci. 22 (2001) 67-70
50. Pasternak G.W. Multiple opiate receptors: deja vu all over again. Neuropharmacology 47 Suppl. 1 (2004) 312-323
51. Pasternak D.A., Pan L., Xu J., Yu R., Xu M., Pasternak G.W., and Pan Y.-X. Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy. J. Neurochem. (2004) 91881-91890
52. Pert C.B., and Snyder S.H. Opiate receptor: demonstration in nervous tissue. Science 179 (1973) 1011-1014
53. Pert A., and Yaksh T.L. Sites of morphine induced analgesia in primate brain: relation to pain pathways. Brain Res. 80 (1974) 135-140
54. Pert C.B., Pasternak G.W., and Snyder S.H. Opiate agonists and antagonists discriminated by receptor binding in brain. Science 182 (1973) 1359-1361
55. Pert C.B., Kuhar M.J., and Snyder S.H. Autoradiographic localization of the opiate receptor in rat brain. Life Sci. 16 (1975) 1849-1853
56. Pick C.G., Cheng J., Paul D., and Pasternak G.W. Genetic influences in opioid analgesic sensitivity in mice. Brain Res. 556 (1991) 295-298
57. Pick C.G., Nejat R., and Pasternak G.W. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains. J. Pharmacol. Exp. Ther. 2265 (1993) 166-171
58. Rossi G.C., and Pasternak G.W. Establishing the molecular biology of opioid behavior of opioid behavior through antisense approaches. In: Weiss B. (Ed). Antisense Oligodeoxynucleotides and Antisense RNA: Novel Pharmacological and Therapeutic Agents (1997), CRC Press, New York 115-130
59. Rossi G.C., Pan Y.-X., Brown G.P., and Pasternak G.W. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6b-glucuronide receptor. FEBS Lett. 369 (1995) 192-196
60. Rossi G.C., Brown G.P., Leventhal L., Yang K., and Pasternak G.W. Novel receptor mechanisms for heroin and morphine-6b-glucuronide analgesia. Neurosci. Lett. 216 (1996) 1-4
61. Rossi G.C., Leventhal L., Pan Y.X., Cole J., Su W., Bodnar R.J., and Pasternak G.W. Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception. J. Pharmacol. Exp. Ther. 281 (1997) 109-114
62. Schuller A.G., King M.A., Zhang J., Bolan E., Pan Y.X., Morgan D.J., Chang A., Czick M.E., Unterwald E.M., Pasternak G.W., and Pintar J.E. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat. Neurosci. 2 (1999) 151-156
63. Schulz S., Schreff M., Koch T., Zimprich A., Gramsch C., Elde R., and Höllt V. Immunolocalization of two mu-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system. Neuroscience 82 (1998) 613-622
64. 3H]etorphine to rat-brain homogenate. Proc. Natl. Acad. Sci. U. S. A. 70 (1973) 1947-1949
65. Sternini C., Spann M., Anton B., Keith Jr. D.E., Bunnett N.W., Von Zastrow M., Evans C., and Brecha N.C. Agonist-selective endocytosis of m opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9241-9246
66. Terenius L. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharmacol. Toxicol. 32 (1973) 317-320
67. Thompson R.C., Mansour A., Akil H., and Watson S.J. Cloning and pharmacological characterization of a rat m opioid receptor. Neuron 11 (1993) 903-913
68. Vanetti M., Kouba M., Wang X., Vogt G., and Hollt V. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett. 311 (1998) 290-294
69. Wang H., and Wessendorf M.W. Equal proportions of small and large DRG neurons express opioid receptor mRNAs. J. Comp. Neurol. 429 (2001) 590-600
70. Wang J.B., Imai Y., Eppler C.M., Gregor P., Spivak C.E., and Uhl G.R. m opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10230-10234
71. Wolozin B.L., and Pasternak G.W. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 6181-6185
72. Zimprich A., Bacher B., and Höllt V. Cloning and expression of an isoform of the rmu-opioid receptor (rmuOR1B). Regul. Pept. 54 (1994) 347-348
73. Zimprich A., Simon T., and Hollt V. Cloning and expression of an isoform of the rat m opioid receptor (rMOR 1 B) which differs in agonist induced desensitization from rMOR1. FEBS Lett. 359 (1995) 142-146